BCIQ Profiles

Company Profile Report
0608 Byondis ADC
BioCentury & Getty Images

Product Development

With breast cancer readout for ADC, Dutch biotech Byondis aims for submission, seeks deal to finance pipeline

Jun 8, 2021 | 7:42 PM GMT

Byondis hopes a pivotal readout for its ADC to treat breast cancer will result in a transformational partnership that will allow the Dutch biotech to develop a pipeline with up to four more clinical candidates by 2023.

Spun out of

Read the full 686 word article

How to gain access

Continue reading with a
two-week free trial.